GSMA
The ICT industry is today taking an unprecedented step forward in tackling climate change with the release of the first-ever science-based pathway to reduce Greenhouse Gas (GHG) emissions across the telecoms sector. This supports the GSMA’s commitment to helping the mobile industry achieve Net Zero carbon emissions by 2050.
The new Science-Based Target (SBT) is the result of a collaboration between the ITU, GeSI, the GSMA, and SBTi to develop a sector-specific decarbonisation pathway that allows ICT companies to set targets in line with the latest climate science. It includes emissions reductions trajectories for mobile, fixed and data centre operators to meet the ambitious Paris Agreement goal of limiting global warming to 1.5°c, designed to substantially reduce the risks and effects of climate change.
Twenty nine operator groups representing 30 per cent of global mobile connections are already committed to SBTs. These include America Movil, AT&T, BT, Bharti Airtel, Deutsche Telekom, Elisa, Far Eastone, KPN, Magyar Telekom, NTT DOCOMO, Orange, Proximus, Reliance Jio Infocomm, Safaricom, Singtel, SK Telecom, STC, Swisscom, T Mobile USA, Taiwan Mobile, TDC, Tele2, Telefónica, Telekom Austria, Telenor, Telia, Telstra, Verizon, and Vodafone.
Many more will now be able to set targets by applying the trajectory recommendations released today.
“Today’s landmark agreement underlines how the ICT sector is taking urgent and unprecedented action in response to the climate emergency,” said Mats Granryd, Director General, GSMA. “The mobile industry is one of the first major sectors in the world to voluntarily set an SBT for emissions reductions. Our sector will form the backbone to the future global economy and has a unique role to play in reaching a Net Zero economy. A decarbonised world will be a digital world, so we must show leadership and take responsibility for driving positive climate action.”
The GSMA is also launching a Climate Toolkit for operators today which includes company guidance for setting science-based targets. Further information is available at: https://www.gsma.com/betterfuture/climate-action-toolkit
Renewable energy to drive emissions reductions
The SBT sets emissions trajectory reductions over the decade (2020-2030) for each ICT sub- sector. For example, mobile network operators adopting the SBT are required to reduce emissions by at least 45 per cent over this period. Companies are required to set one target for their combined Scope 1 and 2 emissions, with additional guidance provided for managing Scope 3 emissions1 .
The switch to renewable and low-carbon electricity is expected to account for the bulk of reductions over this period, alongside efforts by operators to become more energy efficient. Access to renewable energy, which can vary widely depending on an operator’s geographic location is, therefore, a key factor determining an operator’s ability to meet the SBT.
The ICT sector pathway SBT was approved by the Science-Based Target Initiative (SBTi) this month following a consultation period. Full details are provided in the official ITU standard: GHG emissions trajectories for the ICT sector compatible with the UNFCCC Paris Agreement (Ref: Recommendation ITU L.1470).
Mobile industry demonstrating leadership on climate action
Today’s announcement forms part of the GSMA’s climate action roadmap for the mobile industry, which has already seen operators disclose their climate impacts, energy, and emissions via the internationally recognised CDP global disclosure system.2
The GSMA is working with participating operators and partnering with the international community, climate experts and third-party organisations to advance industry progress, establish best practices, and support disclosure and target setting. The work forms part of the industry’s journey to support the delivery of the UN’s Sustainable Development Goals (SDGs), specifically SDG #13 on Climate Action.
The industry is also committed to advancing mobile technology innovations in areas such as big data and IoT that can enable energy efficient and environmental solutions across multiple sectors, including transport, manufacturing, agriculture, building, and energy. A recent report produced by the GSMA and the Carbon Trust calculated that the use of mobile technology enabled a global reduction in emissions of around 2,135 million tonnes CO2 e in 20183 . These emissions savings were almost ten times greater than the global carbon footprint of the mobile industry itself.
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA
1 https://www.epa.gov/greeningepa/greenhouse-gases-epa
View source version on businesswire.com: https://www.businesswire.com/news/home/20200227005095/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
